Fig. 4From: New frontiers in immune checkpoint B7-H3 (CD276) research and drug developmentSummary of the molecular mechanisms of the tumorigenic effects of B7-H3. B7-H3 expressed on cell membrane triggers different signaling cascades to activate downstream molecules that contribute to the malignant behaviors of cancer cellsBack to article page